<?xml version="1.0" encoding="UTF-8"?>
<ref id="cas14811-bib-0022">
 <label>22</label>
 <mixed-citation publication-type="journal" id="cas14811-cit-0022">
  <string-name>
   <surname>Owen</surname>
   <given-names>DH</given-names>
  </string-name>, 
  <string-name>
   <surname>Alexander</surname>
   <given-names>AJ</given-names>
  </string-name>, 
  <string-name>
   <surname>Konda</surname>
   <given-names>B</given-names>
  </string-name>, et al. 
  <article-title>Combination therapy with capecitabine and temozolomide in patients with low and high grade neuroendocrine tumors, with an exploratory analysis of O 
   <sup>6</sup>‐methylguanine DNA methyltransferase as a biomarker for response
  </article-title>. 
  <source xml:lang="en">Oncotarget</source>. 
  <year>2017</year>;
  <volume>8</volume>:
  <fpage>104046</fpage>‐
  <lpage>104056</lpage>.
  <pub-id pub-id-type="pmid">29262620</pub-id>
 </mixed-citation>
</ref>
